Back

A C. elegans model for functional analysis of ADPKD variants in cilia, extracellular vesicles, and sensory signaling

Wang, J.; Nava Cruz, C.; Walsh, J. D.; desRanleau, E.; Nikonorova, I. A.; Barr, M. M.

2026-04-15 genetics
10.64898/2026.04.14.718433 bioRxiv
Show abstract

Interpreting the pathogenic significance of missense variants in human disease gene candidates remains a major challenge in precision medicine. Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic cause of kidney failure and caused by mutations in the PKD1 or PKD2 genes that encode polycystin-1 and polycystin-2. Here, we establish C. elegans as a platform for the functional classification of PC2 variants by characterizing PKD-2C180S, the C. elegans ortholog of the likely pathogenic human variant PC2C331S. Using CRISPR/Cas9 endogenous genome editing combined with dual-color fluorescent reporters and super-resolution imaging, we show that PKD-2C180S severely reduces protein stability, abolishes ciliary and extracellular vesicle (EV) localization, and eliminates sensory function comparable to a pkd-2 null allele. In heterozygous animals, PKD-2C180S is recessive and exerts no dominant-negative effect on wild-type PKD-2 trafficking, protein levels, or function, establishing that PKD-2 is haplosufficient in this model. PKD-2C180S also abolishes ciliary and EV localization of the PC1 homolog LOV-1 and reduces LOV-1 cell body levels comparable to pkd-2 null animals, consistent with PC2 functioning as a molecular chaperone for PC1 stability and trafficking. Genetic epistasis experiments show that PKD-2C180S protein levels are unaffected in lov-1 mutants, indicating that the PKD-2C180S mutation acts prior to complex assembly. Quantitative analysis reveals that LOV-1*PKD-2 complexes are more stable at the ciliary membrane and more efficiently packaged into EVs than PKD-2 lacking LOV-1. Together, this work demonstrates that PC2C331S may act recessively via loss of polycystin complex function and establishes a C. elegans pipeline for the mechanistic classification of ADPKD-associated variants.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Nature Communications
4913 papers in training set
Top 16%
10.5%
2
The American Journal of Human Genetics
206 papers in training set
Top 0.4%
10.1%
3
Molecular Cell
308 papers in training set
Top 2%
8.2%
4
Developmental Cell
168 papers in training set
Top 3%
7.2%
5
Cell
370 papers in training set
Top 4%
4.9%
6
Cell Reports
1338 papers in training set
Top 11%
4.3%
7
Nature Genetics
240 papers in training set
Top 2%
4.2%
8
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 17%
4.0%
50% of probability mass above
9
eLife
5422 papers in training set
Top 25%
3.6%
10
Nature Metabolism
56 papers in training set
Top 0.9%
2.1%
11
Genetics
225 papers in training set
Top 2%
2.1%
12
PLOS Genetics
756 papers in training set
Top 7%
2.1%
13
Science Advances
1098 papers in training set
Top 14%
1.9%
14
Nature
575 papers in training set
Top 10%
1.9%
15
Current Biology
596 papers in training set
Top 8%
1.9%
16
Science
429 papers in training set
Top 13%
1.8%
17
Human Molecular Genetics
130 papers in training set
Top 2%
1.8%
18
Nucleic Acids Research
1128 papers in training set
Top 11%
1.7%
19
Science Translational Medicine
111 papers in training set
Top 3%
1.7%
20
Genes & Development
90 papers in training set
Top 0.6%
1.5%
21
Disease Models & Mechanisms
119 papers in training set
Top 1%
1.5%
22
JCI Insight
241 papers in training set
Top 4%
1.5%
23
Cell Genomics
162 papers in training set
Top 4%
1.3%
24
EMBO Molecular Medicine
85 papers in training set
Top 3%
1.0%
25
Scientific Reports
3102 papers in training set
Top 73%
0.8%
26
Journal of the American Society of Nephrology
52 papers in training set
Top 0.5%
0.8%
27
Genetics in Medicine
69 papers in training set
Top 1%
0.7%
28
Kidney International
25 papers in training set
Top 0.4%
0.7%
29
EMBO reports
136 papers in training set
Top 8%
0.6%
30
GENETICS
189 papers in training set
Top 2%
0.5%